Target-Specific Strategies to Modify the Course of Parkinson's: Is Iron Chelation Safe?

Mestre, Tiago A; Schlossmacher, Michael G

Mestre, Tiago A; Schlossmacher, Michael G.

Afiliação

Mestre TA; Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute/University of Ottawa Brain and Research Institute, Ottawa, Ontario, Canada.
Schlossmacher MG; Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa Brain and Research Institute, Ottawa, Ontario, Canada.

Mov Disord ; 38(5): 740-741, 2023 05.

Article em En | MEDLINE | ID: mdl-36945748

Assuntos

Doença de Parkinson; Humanos; Doença de Parkinson/tratamento farmacológico; Quelantes de Ferro/efeitos adversos; Ferro

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google